N Amirizadeh
Overview
Explore the profile of N Amirizadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khorshidfar M, Chegini A, Pourfathollah A, Oodi A, Amirizadeh N
Indian J Hematol Blood Transfus
. 2019 Aug;
35(3):538-543.
PMID: 31388270
ABO discrepancies are recognized when the reactions obtained in the forward type do not "match" the reactions obtained in the reverse type. Discrepant results are often caused by a variant...
2.
Ferdowsi S, Atarodi K, Amirizadeh N, Toogeh G, Azarkeivan A, Shirkoohi R, et al.
Int J Lab Hematol
. 2015 May;
37(5):661-7.
PMID: 26011312
Introduction: The JAK2V617F mutation has emerged in recent years as a diagnostic as well as a treatment target in patients with polycythemia vera (PV) and essential thrombocythemia (ET). The disease...
3.
Fallah P, Amirizadeh N, Poopak B, Toogeh G, Arefian E, Kohram F, et al.
Int J Lab Hematol
. 2015 Apr;
37(4):560-8.
PMID: 25833191
Introduction: Chronic myeloid leukemia (CML) is caused by reciprocal translocation in hematopoietic stem cells (HSCs). This translocation forms the BCR-ABL1 oncogene, which alters several signaling pathways that control malignancy. CML...
4.
Vahabi S, Amirizadeh N, Shokrgozar M, Mofeed R, Mashhadi A, Aghaloo M, et al.
Chang Gung Med J
. 2012 Apr;
35(1):28-37.
PMID: 22483425
Background: Recently, tissue engineering has been introduced as a regenerative treatment for bone defects. There is some evidence showing bone regeneration from mesenchymal stem cells (MSC) loaded on hydroxyapatite β-tricalcium...
5.
Ahmadzadeh N, Yari F, Amirizadeh N, Khorramizadeh M
Int J Lab Hematol
. 2011 Jun;
33(6):586-92.
PMID: 21707938
Introduction: During recent years, the need for platelet concentrate (PC) has increased. Infusible platelet membranes (IPM) have been developed as an alternative to standard PCs, with the additional advantage of...
6.
Kazemnejad S, Allameh A, Seoleimani M, Gharehbaghian A, Mohammadi Y, Amirizadeh N, et al.
Int J Artif Organs
. 2008 Jul;
31(6):500-7.
PMID: 18609502
Aim: To supporting growth and functional differentiation of adult stem cells into hepatocytes in a well-controlled manner, we performed differentiation of human bone marrow mesenchymal stem cells (hBMSCs) to hepatocytes-like...
7.
Kazemnejad S, Allameh A, Gharehbaghian A, Soleimani M, Amirizadeh N, Jazayeri M
Vox Sang
. 2008 Jun;
95(2):149-58.
PMID: 18557826
Objectives: The aim of this study was to find out substitution effect of fetal bovine serum (FBS) with human platelet releasate (HPR) as a major growth factor source during expansion...
8.
Najmabadi H, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, Amirizadeh N
Hemoglobin
. 2001 Sep;
25(3):285-96.
PMID: 11570721
Beta-thalassemia is the most common hereditary disease in Iran. More than two million carriers of beta-thalassemia live in Iran. Since the Iranian population is a mixture of different ethnic groups,...